A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)

Clinical trial NCT04537806 · TERMINATED

Trial details

NCT number: NCT04537806
Sponsor: Sage Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome COVID-19

Start date: 2020-12-18
Primary completion: 2021-07-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.